Oncorus to Present at the H.C. Wainwright Global Investment Conference
May 17 2022 - 7:00AM
Oncorus, Inc. (Nasdaq: ONCR), a viral immunotherapies company
focused on driving innovation to transform outcomes for cancer
patients, today announced that President and Chief Executive
Officer, Theodore (Ted) Ashburn, M.D., Ph.D., will present an
update on the Company’s progress at the H.C. Wainwright Global
Investment Conference. The presentation will be available for
on-demand viewing starting Tuesday, May 24, 2022 at 7:00 a.m. ET.
A webcast of the presentation can be accessed by visiting the
Investors & Media section of Oncorus’ website
at https://investors.oncorus.com/. A replay of the webcast
will be archived on Oncorus’ site for 90 days following the
event.
About Oncorus
At Oncorus, we are focused on driving innovation to deliver
next-generation viral immunotherapies to transform outcomes for
cancer patients. We are advancing a portfolio of intratumorally
(iTu) and intravenously (IV) administered viral immunotherapies for
multiple indications with significant unmet need based on our
Herpes Simplex Virus (HSV) and selectively self-amplifying viral
RNA Immunotherapy Platforms.
Designed to deliver next-generation viral immunotherapy impact,
our HSV Platform improves upon key characteristics of this
therapeutic class to enhance systemic activity. Our lead HSV
program, ONCR-177, is designed to be directly administered into a
tumor, resulting in high local concentrations of the therapeutic
agent and its five encoded transgenes, as well as low systemic
exposure to the therapy, which could limit systemic toxicities. Our
pioneering selectively self-amplifying vRNA Immunotherapy Platform,
highlighted by our product candidates ONCR-021 and ONCR-788,
involves a highly innovative, novel combination of RNA and
oncolytic virus-based modalities designed to realize the potential
of RNA medicines for cancer.
Please visit www.oncorus.com to learn more.
Investor Contact:Stern Investor
Relations Julie SeidelJulie.seidel@sternir.com
Oncorus (NASDAQ:ONCR)
Historical Stock Chart
From Aug 2024 to Sep 2024
Oncorus (NASDAQ:ONCR)
Historical Stock Chart
From Sep 2023 to Sep 2024